Artemisinins target GABAA receptor signaling and impair α cell identity.
Type 1 diabetes is characterized by the destruction of pancreatic beta cells, and generating new insulin-producing cells from other cell types is a major aim of regenerative medicine. One promising approach is transdifferentiation of developmentally related pancreatic cell types including...
Päätekijät: | Li, J, Casteels, T, Frogne, T, Ingvorsen, C, Honoré, C, Courtney, M, Huber, K, Schmitner, N, Kimmel, R, Romanov, R, Sturtzel, C, Lardeau, C, Klughammer, J, Farlik, M, Sdelci, S, Vieira, A, Avolio, F, Briand, F, Baburin, I, Májek, P, Pauler, F, Penz, T, Stukalov, A, Gridling, M, Parapatics, K, Barbieux, C, Berishvili, E, Spittler, A, Colinge, J, Bennett, K, Hering, S, Sulpice, T, Bock, C, Distel, M, Harkany, T, Meyer, D, Superti-Furga, G, Collombat, P, Hecksher-Sørensen, J, Kubicek, S |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Elsevier
2016
|
Samankaltaisia teoksia
-
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.
Tekijä: Huber, K, et al.
Julkaistu: (2014) -
Pdx1 is post-translationally modified in vivo and serine 61 is the principal site of phosphorylation.
Tekijä: Thomas Frogne, et al.
Julkaistu: (2012-01-01) -
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
Tekijä: Licciardello, M, et al.
Julkaistu: (2014) -
Differential DNA Methylation Analysis without a Reference Genome
Tekijä: Johanna Klughammer, et al.
Julkaistu: (2015-12-01) -
Physics of semiconductor devices /
Tekijä: 353944 Colinge, Jean Pierre, et al.
Julkaistu: (2002)